Industrial policy against pandemics

Reda Cherif and Fuad Hasanov

Industrial and Corporate Change, 2025, vol. 34, issue 5, 1029-1043

Abstract: The coronavirus disease 2019 (COVID-19) pandemic illustrated the inability of the market to meet the needed production scale and speed of essential medical products. The state should adopt a risk-based approach, allowing for experimentation with various technological solutions such as vaccines and tests, while ramping up their production. The intervention should resolve uncertainty, combine resources, coordinate technological choices, lift barriers to entry, ensure knowledge sharing, and support the value chain. The cost of this strategy is dwarfed by the economic fallout of a pandemic. Universal testing, an overlooked solution, is a key component of an infrastructure against future pandemics.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1093/icc/dtab042 (application/pdf)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oup:indcch:v:34:y:2025:i:5:p:1029-1043.

Ordering information: This journal article can be ordered from
https://academic.oup.com/journals

Access Statistics for this article

Industrial and Corporate Change is currently edited by Josef Chytry

More articles in Industrial and Corporate Change from Oxford University Press and the Associazione ICC Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, UK.
Bibliographic data for series maintained by Oxford University Press ().